Testosterone Therapy in Hypogonadal Men Treated With Opioids
Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of testosterone replacement therapy in
men with low testosterone due to opioid treatment on body composition, the haemostatic
system, glucose metabolism, muscle function, pain sensitivity, pain modulation, lipids,
sexual function and quality of life.
Male patients on opioids for non-malignant diseases aged 18-59 years diagnosed with
hypogonadotrophic hypogonadism, referred from day hospitals and outpatient populations. 40
patients are randomized to either testosterone undecanoate i.m. or placebo i.m., i.e. 20
patients per arm
A double blinded randomized placebo controlled trial